BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 21621225)

  • 1. Premotor cognitive status in a cohort of incident Parkinson disease patients (NEDICES).
    Sánchez-Ferro Á; Benito-León J; Mitchell AJ; Louis ED; Posada IJ; Trincado R; Villarejo A; Bermejo-Pareja F
    J Neurol Sci; 2011 Nov; 310(1-2):211-5. PubMed ID: 21621225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based case-control study of cognitive function in early Parkinson's disease (NEDICES).
    Benito-León J; Louis ED; Posada IJ; Sánchez-Ferro Á; Trincado R; Villarejo A; Mitchell AJ; Bermejo-Pareja F
    J Neurol Sci; 2011 Nov; 310(1-2):176-82. PubMed ID: 21774946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of cognitive decline in premotor Parkinson's disease: a prospective study (NEDICES).
    Sánchez-Ferro Á; Benito-León J; Louis ED; Mitchell AJ; Molina-Arjona JA; Trincado R; Villarejo A; Bermejo-Pareja F
    Mov Disord; 2013 Feb; 28(2):161-8. PubMed ID: 23239285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rate of cognitive decline in Parkinson disease.
    Aarsland D; Andersen K; Larsen JP; Perry R; Wentzel-Larsen T; Lolk A; Kragh-Sørensen P
    Arch Neurol; 2004 Dec; 61(12):1906-11. PubMed ID: 15596611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brief cognitive assessment in the early stages of Parkinson disease.
    Bugalho P; Vale J
    Cogn Behav Neurol; 2011 Dec; 24(4):169-73. PubMed ID: 22045168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive profile of patients with newly diagnosed Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B
    Neurology; 2005 Oct; 65(8):1239-45. PubMed ID: 16247051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking and cognitive function in Parkinson's disease.
    Weisskopf MG; Grodstein F; Ascherio A
    Mov Disord; 2007 Apr; 22(5):660-5. PubMed ID: 17266085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive symptoms in Parkinson disease correlate with impaired global and specific cognitive performance.
    Fernandez HH; See RH; Gary MF; Bowers D; Rodriguez RL; Jacobson C; Okun MS
    J Geriatr Psychiatry Neurol; 2009 Dec; 22(4):223-7. PubMed ID: 19429848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cognition deterioration in Parkinson's disease: associated risk factors].
    Errea JM; Ara JR
    Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based case-control study of cognitive function in essential tremor.
    Benito-León J; Louis ED; Bermejo-Pareja F;
    Neurology; 2006 Jan; 66(1):69-74. PubMed ID: 16401849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrumental activities of daily living in Parkinson's disease dementia as compared with Alzheimer's disease: relationship to motor disability and cognitive deficits: a pilot study.
    Rasovska H; Rektorova I
    J Neurol Sci; 2011 Nov; 310(1-2):279-82. PubMed ID: 21851954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins and cognitive functioning in the elderly: a population-based study.
    Benito-León J; Louis ED; Vega S; Bermejo-Pareja F
    J Alzheimers Dis; 2010; 21(1):95-102. PubMed ID: 20413854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the status of cognition among Parkinson's disease patients in Xi'an.].
    Wang RL; Qu QM; Cao HM; Zhe X; Qiao J; Guo F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar; 31(3):329-32. PubMed ID: 20510065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frontal assessment battery in patients with Parkinson disease in a Turkish population.
    Kenangil G; Orken DN; Ur E; Forta H
    Cogn Behav Neurol; 2010 Mar; 23(1):26-8. PubMed ID: 20299860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity of cognitive dysfunction in Parkinson's disease: a cohort study.
    Verleden S; Vingerhoets G; Santens P
    Eur Neurol; 2007; 58(1):34-40. PubMed ID: 17483583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-year population-based study of psychosis in Parkinson disease.
    Forsaa EB; Larsen JP; Wentzel-Larsen T; Goetz CG; Stebbins GT; Aarsland D; Alves G
    Arch Neurol; 2010 Aug; 67(8):996-1001. PubMed ID: 20697051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive decline in high-functioning older persons is associated with an increased risk of hospitalization.
    Chodosh J; Seeman TE; Keeler E; Sewall A; Hirsch SH; Guralnik JM; Reuben DB
    J Am Geriatr Soc; 2004 Sep; 52(9):1456-62. PubMed ID: 15341546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.